Pérez-Torras S - Search Results

1

Pastor-Anglada M, Pérez-Torras S. Pastor-Anglada M, et al. Front Pharmacol. 2018 Jun 14;9:627. doi: 10.3389/fphar.2018.00627. eCollection 2018. Front Pharmacol. 2018. PMID: 29962948 Free PMC article. Review.

2

Adenoviral-mediated overexpression of human equilibrative nucleoside transporter 1 (hENT1) enhances gemcitabine response in human pancreatic cancer.

Pérez-Torras S, García-Manteiga J, Mercadé E, Casado FJ, Carbó N, Pastor-Anglada M, Mazo A. Pérez-Torras S, et al. Biochem Pharmacol. 2008 Aug 1;76(3):322-9. doi: 10.1016/j.bcp.2008.05.011. Epub 2008 May 20. Biochem Pharmacol. 2008. PMID: 18589402

3

New role of the human equilibrative nucleoside transporter 1 (hENT1) in epithelial-to-mesenchymal transition in renal tubular cells.

Guillén-Gómez E, Pinilla-Macua I, Pérez-Torras S, Choi DS, Arce Y, Ballarín JA, Pastor-Anglada M, Díaz-Encarnación MM. Guillén-Gómez E, et al. J Cell Physiol. 2012 Apr;227(4):1521-8. doi: 10.1002/jcp.22869. J Cell Physiol. 2012. PMID: 21678404

4

Role of the transporter regulator protein (RS1) in the modulation of concentrative nucleoside transporters (CNTs) in epithelia.

Errasti-Murugarren E, Fernández-Calotti P, Veyhl-Wichmann M, Diepold M, Pinilla-Macua I, Pérez-Torras S, Kipp H, Koepsell H, Pastor-Anglada M. Errasti-Murugarren E, et al. Mol Pharmacol. 2012 Jul;82(1):59-67. doi: 10.1124/mol.111.076992. Epub 2012 Apr 9. Mol Pharmacol. 2012. PMID: 22492015

5

Aquaporin 3 (AQP3) participates in the cytotoxic response to nucleoside-derived drugs.

Trigueros-Motos L, Pérez-Torras S, Casado FJ, Molina-Arcas M, Pastor-Anglada M. Trigueros-Motos L, et al. BMC Cancer. 2012 Sep 27;12:434. doi: 10.1186/1471-2407-12-434. BMC Cancer. 2012. PMID: 23017148 Free PMC article.

6

Concentrative nucleoside transporter 1 (hCNT1) promotes phenotypic changes relevant to tumor biology in a translocation-independent manner.

Pérez-Torras S, Vidal-Pla A, Cano-Soldado P, Huber-Ruano I, Mazo A, Pastor-Anglada M. Pérez-Torras S, et al. Cell Death Dis. 2013 May 30;4(5):e648. doi: 10.1038/cddis.2013.173. Cell Death Dis. 2013. PMID: 23722537 Free PMC article.

7

Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets.

Pastor-Anglada M, Pérez-Torras S. Pastor-Anglada M, et al. Front Pharmacol. 2015 Feb 10;6:13. doi: 10.3389/fphar.2015.00013. eCollection 2015. Front Pharmacol. 2015. PMID: 25713533 Free PMC article. Review.

8

Ribonucleotide reductase is an effective target to overcome gemcitabine resistance in gemcitabine-resistant pancreatic cancer cells with dual resistant factors.

Minami K, Shinsato Y, Yamamoto M, Takahashi H, Zhang S, Nishizawa Y, Tabata S, Ikeda R, Kawahara K, Tsujikawa K, Chijiiwa K, Yamada K, Akiyama S, Pérez-Torras S, Pastor-Anglada M, Furukawa T, Yasuo T. Minami K, et al. J Pharmacol Sci. 2015 Mar;127(3):319-25. doi: 10.1016/j.jphs.2015.01.006. Epub 2015 Feb 7. J Pharmacol Sci. 2015. PMID: 25837929 Free article.

9

Transportome Profiling Identifies Profound Alterations in Crohn's Disease Partially Restored by Commensal Bacteria.

Pérez-Torras S, Iglesias I, Llopis M, Lozano JJ, Antolín M, Guarner F, Pastor-Anglada M. Pérez-Torras S, et al. J Crohns Colitis. 2016 Jul;10(7):850-9. doi: 10.1093/ecco-jcc/jjw042. Epub 2016 Feb 13. J Crohns Colitis. 2016. PMID: 26874350

10

Pharmacogenomic analyzis of the responsiveness of gastrointestinal tumor cell lines to drug therapy: A transportome approach.

Grañé-Boladeras N, Pérez-Torras S, Lozano JJ, Romero MR, Mazo A, Marín JJG, Pastor-Anglada M. Grañé-Boladeras N, et al. Pharmacol Res. 2016 Nov;113(Pt A):364-375. doi: 10.1016/j.phrs.2016.09.007. Epub 2016 Sep 9. Pharmacol Res. 2016. PMID: 27620070

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters